Cargando…

Effects of lasofoxifene and bazedoxifene on B cell development and function

The third generation selective estrogen receptor modulators lasofoxifene (las) and bazedoxifene (bza) are indicated for treatment of postmenopausal osteoporosis. 17β-Estradiol (E2) and the second generation SERM raloxifene (ral) have major effects on the immune system, particularly on B cells. Treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernardi, Angelina I, Andersson, Annica, Grahnemo, Louise, Nurkkala-Karlsson, Merja, Ohlsson, Claes, Carlsten, Hans, Islander, Ulrika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386916/ https://www.ncbi.nlm.nih.gov/pubmed/25866629 http://dx.doi.org/10.1002/iid3.37

Ejemplares similares

Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis
por: Andersson, Annica, et al.
Publicado: (2016)

Trabecular bone loss in collagen antibody-induced arthritis
por: Grahnemo, Louise, et al.
Publicado: (2015)

Possible role of lymphocytes in glucocorticoid-induced increase in trabecular bone mineral density
por: Grahnemo, Louise, et al.
Publicado: (2015)

Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis
por: Andersson, Annica, et al.
Publicado: (2015)

Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss
por: Stubelius, Alexandra, et al.
Publicado: (2016)

Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis
por: Islander, Ulrika, et al.
Publicado: (2011)

Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation
por: Jochems, Caroline, et al.
Publicado: (2005)

Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1(*/* )mice with collagen-induced chronic arthritis
por: Jochems, Caroline, et al.
Publicado: (2010)

The role of total and cartilage-specific estrogen receptor alpha expression for the ameliorating effect of estrogen treatment on arthritis
por: Engdahl, Cecilia, et al.
Publicado: (2014)

Bazedoxifene does not share estrogens effects on IgG sialylation
por: Gupta, Priti, et al.
Publicado: (2023)

SUN-744 Phosphorylation Site S122 in Estrogen Receptor α Has a Tissue-Dependent Role in Female Mice
por: Gustafsson, Karin L, et al.
Publicado: (2020)

Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2009)

Lasofoxifene: Evidence of its therapeutic value in osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2010)

Probiotics Protect Mice from Ovariectomy-Induced Cortical Bone Loss
por: Ohlsson, Claes, et al.
Publicado: (2014)

Estren promotes androgen phenotypes in primary lymphoid organs and submandibular glands
por: Islander, Ulrika, et al.
Publicado: (2005)

Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008)

Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis
por: Deminger, Anna, et al.
Publicado: (2020)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2011)

Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
por: Gennari, Luigi, et al.
Publicado: (2010)

Synthesis of Lasofoxifene, Nafoxidine and Their Positional Isomers via the Novel Three-Component Coupling Reaction
por: Nakata, Kenya, et al.
Publicado: (2010)

Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer
por: Lainé, Muriel, et al.
Publicado: (2021)

Low Circulating Valine Associate With High Risk of Hip Fractures
por: Grahnemo, Louise, et al.
Publicado: (2023)

Interleukin 17A: a Janus-faced regulator of osteoporosis
por: Scheffler, J. M., et al.
Publicado: (2020)

Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan
por: Ohta, H., et al.
Publicado: (2014)

Bazedoxifene/conjugated estrogens in combination with leuprolide for the treatment of endometriosis
por: Hill, Amanda M., et al.
Publicado: (2018)

Effects of conjugated estrogen and bazedoxifene on hemostasis and thrombosis in mice
por: Noirrit, Emmanuelle, et al.
Publicado: (2019)

ERα Signaling in a Subset of CXCL12‐Abundant Reticular Cells Regulates Trabecular Bone in Mice
por: Scheffler, Julia M, et al.
Publicado: (2022)

Update on bazedoxifene: A novel selective estrogen receptor modulator
por: Biskobing, Diane M
Publicado: (2007)

Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
por: Komm, Barry S, et al.
Publicado: (2012)

Bazedoxifene as a novel strategy for treatment of pancreatic and gastric adenocarcinoma
por: Burkhardt, Claudia, et al.
Publicado: (2019)

Bazedoxifene Suppresses Intracellular Mycobacterium tuberculosis Growth by Enhancing Autophagy
por: Ouyang, Qi, et al.
Publicado: (2020)

Conjugated Estrogens and Bazedoxifene Improve β Cell Function in Obese Menopausal Women
por: Lovre, Dragana, et al.
Publicado: (2019)

Wnt16 Overexpression in Osteoblasts Increases the Subchondral Bone Mass but has no Impact on Osteoarthritis in Young Adult Female Mice
por: Törnqvist, Anna E., et al.
Publicado: (2020)

A probiotic mix partially protects against castration-induced bone loss in male mice
por: Lawenius, Lina, et al.
Publicado: (2022)

Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination
por: Mirkin, Sebastian, et al.
Publicado: (2013)

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain
por: Darbà, Josep, et al.
Publicado: (2013)

Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene
por: Kagan, Risa, et al.
Publicado: (2016)

The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause
por: Lello, Stefano, et al.
Publicado: (2017)

Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
por: Wei, Jia, et al.
Publicado: (2019)

Bazedoxifene inhibits sustained STAT3 activation and increases survival in GBM
por: Wightman, Samantha M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7j4n9d4lcdus1eg51ukhbcjib5